Skip Nav Destination

Issue Archive

Select Year

Issue

Volume 17, Issue 2

March-April 2020

In this Issue

Ask the Hematologist
Clinical Trials Corner
Diffusion
Features
Headlines from Washington
Image Challenge
Mini Review
President’s Column

Ask the Hematologist

Fertility Preservation for Women With Hematologic Malignancies

Alison Loren, MD, MS

View Articletitled, Fertility Preservation for Women With Hematologic Malignancies

Clinical Trials Corner

Bispecific Antibodies in Multiple Myeloma: Do These T cell-Recruiting Antibodies Make a Difference?

Sabrin Tahri, MD,Irene M. Ghobrial, MD,Oliver C. Lomas, MD, PhD

View Articletitled, Bispecific Antibodies in Multiple Myeloma: Do These T cell-Recruiting Antibodies Make a Difference?

Diffusion

Act Fast! Making a Difference After Traumatic Brain Injury With Tranexamic Acid

Eric Tseng, MD, MScCH, FRCPC

View Articletitled, Act Fast! Making a Difference After Traumatic Brain Injury With Tranexamic Acid

Testosterone Therapy in Men Doubles the Risk for Venous Thromboembolism

Damon Houghton, MD,Stephan Moll, MD

View Articletitled, Testosterone Therapy in Men Doubles the Risk for Venous Thromboembolism

CAR Design, Independent of Costimulatory Domain, Impacts Safety and Immunogenicity of CAR T-cell Therapy

Frederick Locke, MD

View Articletitled, CAR Design, Independent of Costimulatory Domain, Impacts Safety and Immunogenicity of CAR T-cell Therapy

Identification of Malignant Cell Populations Years Before Development of Treatment-related Leukemia in Patients With Myeloma

Amy DeZern, MD, MHS

View Articletitled, Identification of Malignant Cell Populations Years Before Development of Treatment-related Leukemia in Patients With Myeloma

Menin Inhibitors: A New Hope in MLL-Rearranged Leukemia?

Steven Lane, MBBS, PhD, FRACP, FRCPA,Renee Squires, MBBS

View Articletitled, Menin Inhibitors: A New Hope in MLL-Rearranged Leukemia?

Outcomes for Children With SR-ALL: More Is Not Always Better

David T. Teachey, MD,Caroline Diorio, MD, FRCPC, FAAP

View Articletitled, Outcomes for Children With SR-ALL: More Is Not Always Better

The MEDALIST Trial: Are We on the Podium for Lower-Risk MDS?

Kristen M. O'Dwyer, MD

View Articletitled, The MEDALIST Trial: Are We on the Podium for Lower-Risk MDS?

Picking a Partner: As in Life, it Matters for MYC

Brad Kahl, MD

View Articletitled, Picking a Partner: As in Life, it Matters for MYC

How FLT3-ITDs and NPM1 Insertions Maneuver Into AML Using the Lymphoid Enzyme TdT to Initiate Replication Slippage

Annette S. Kim, MD, PhD,John C. LaMacchia, MD, PhD

View Articletitled, How FLT3-ITDs and NPM1 Insertions Maneuver Into AML Using the Lymphoid Enzyme TdT to Initiate Replication Slippage

Does Renal Function Deteriorate in Individuals With Sickle Cell Trait and Sickle Cell Disease? Now We Know

Ifeyinwa (Ify) Osunkwo, MD, MPH,Elna Saah, MD

View Articletitled, Does Renal Function Deteriorate in Individuals With Sickle Cell Trait and Sickle Cell Disease? Now We Know

Features

Update on the ASH Research Collaborative Data Hub

William A. Wood, MD, MPH

View Articletitled, Update on the ASH Research Collaborative Data Hub

Strengthening the Potential of Genetic Diagnoses: A Conversation With Drs. Lucy Godley and Jorge Di Paola

Laura C. Michaelis, MD,Lucy A. Godley, MD, PhD,Jorge Di Paola, MD

View Articletitled, Strengthening the Potential of Genetic Diagnoses: A Conversation With Drs. Lucy Godley and Jorge Di Paola

Headlines from Washington

For Some Hematologists, Advocacy Takes On a More Personal Meaning

ASH Staff

View Articletitled, For Some Hematologists, Advocacy Takes On a More Personal Meaning

Image Challenge

Bite Cells Abound

Lindsey Shantzer, MD,Kelly Davidson, MD

View Articletitled, Bite Cells Abound

Mini Review

Precision Medicine in Clonal Hematopoiesis: New Data on Risk for Transformation

Adam Mead, MD, PhD,Jennifer O'Sullivan, MD

View Articletitled, Precision Medicine in Clonal Hematopoiesis: New Data on Risk for Transformation

President’s Column

Improving the Poor Prognosis of Grant Applications

Stephanie Lee, MD, MPH

View Articletitled, Improving the Poor Prognosis of Grant Applications

Cover Image

Cover Image

All Issues

Email alerts

Latest Issue Alert

Continuous Publishing Alert

New Journal Content Alert

Latest
Most Read

Sequencing of Therapy Matters in the Era of Autologous Chimeric Antigen Receptor T-cell Therapy

Restoring T-cell Cytotoxicity To Correct Familial Hemophagocytic Lymphohistiocytosis

Not So Benign
This Is Not Your Father’s Thrombotic Thrombocytopenic Purpura

Perspective
Procedure Skills in Hematology Training: Lost Cause or Worth Fighting For?

ASH Committees Visit Capitol Hill in Support of Funding

Table of Contents

Ask the Hematologist

Fertility Preservation for Women With Hematologic Malignancies

Clinical Trials Corner

Bispecific Antibodies in Multiple Myeloma: Do These T cell-Recruiting Antibodies Make a Difference?

Diffusion

Act Fast! Making a Difference After Traumatic Brain Injury With Tranexamic Acid

Testosterone Therapy in Men Doubles the Risk for Venous Thromboembolism

CAR Design, Independent of Costimulatory Domain, Impacts Safety and Immunogenicity of CAR T-cell Therapy

Identification of Malignant Cell Populations Years Before Development of Treatment-related Leukemia in Patients With Myeloma

Menin Inhibitors: A New Hope in MLL-Rearranged Leukemia?

Outcomes for Children With SR-ALL: More Is Not Always Better

The MEDALIST Trial: Are We on the Podium for Lower-Risk MDS?

Picking a Partner: As in Life, it Matters for MYC

How FLT3-ITDs and NPM1 Insertions Maneuver Into AML Using the Lymphoid Enzyme TdT to Initiate Replication Slippage

Does Renal Function Deteriorate in Individuals With Sickle Cell Trait and Sickle Cell Disease? Now We Know

Features

Update on the ASH Research Collaborative Data Hub

Strengthening the Potential of Genetic Diagnoses: A Conversation With Drs. Lucy Godley and Jorge Di Paola

Headlines from Washington

For Some Hematologists, Advocacy Takes On a More Personal Meaning

Image Challenge

Bite Cells Abound

Mini Review

Precision Medicine in Clonal Hematopoiesis: New Data on Risk for Transformation

President’s Column

Improving the Poor Prognosis of Grant Applications

Email alerts

ASH Publications

American Society of Hematology

Issue Archive

Table of Contents

Ask the Hematologist

Clinical Trials Corner

Diffusion

Features

Headlines from Washington

Image Challenge

Mini Review

President’s Column

Cover Image

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only